AIMS/HYPOTHESIS: The Andres clamp technique, which requires accurate and timely determination of glucose, utilizes the Beckman or Yellow Springs Instruments (YSI) glucose analyzers. Both instruments require maintenance, a dedicated operator, preparation of a plasma sample, and a duplicate measurement that takes ≥2 minutes. The Nova StatStrip glucose meter was evaluated for accuracy, reliability, and near-real-time availability of glucose. METHODS: Blood samples from 24 patients who underwent 6-hour clamp studies and 12 patients who had a standardized meal tolerance test (SMT) were measured. Specimens were analyzed simultaneously and immediately upon collection by Beckman, YSI, and Nova. RESULTS: Of 1004 data pairs for the Nova device versus Beckman, the Nova data points ranged from 32 to 444, while Beckman ranged from 42 to 412. The coefficient for the slope of Beckman versus Nova was 1.009 (r = 0.978). Using error grid analysis, the number and percentage of values for Nova were 976 (97.2%) in the A zone and 28 (2.8%) in the B zone. Of 399 data pairs for the Nova device versus YSI, the Nova data points ranged from 46 to 255, whereas YSI ranged from 47 to 231. The coefficient for the slope of YSI versus Nova was 1.023 (r = 0.989). All Nova readings fell in the A zone. Time required for final reading, in duplicate, was 15 seconds for Nova and 120-180 seconds for Beckman and YSI. CONCLUSIONS: The simplicity of Nova and its reliability, accuracy, and speed make it an acceptable replacement device for Beckman and YSI in the conduct of clamps, especially when perturbations require rapid glucose determination.
AIMS/HYPOTHESIS: The Andres clamp technique, which requires accurate and timely determination of glucose, utilizes the Beckman or Yellow Springs Instruments (YSI) glucose analyzers. Both instruments require maintenance, a dedicated operator, preparation of a plasma sample, and a duplicate measurement that takes ≥2 minutes. The Nova StatStrip glucose meter was evaluated for accuracy, reliability, and near-real-time availability of glucose. METHODS: Blood samples from 24 patients who underwent 6-hour clamp studies and 12 patients who had a standardized meal tolerance test (SMT) were measured. Specimens were analyzed simultaneously and immediately upon collection by Beckman, YSI, and Nova. RESULTS: Of 1004 data pairs for the Nova device versus Beckman, the Nova data points ranged from 32 to 444, while Beckman ranged from 42 to 412. The coefficient for the slope of Beckman versus Nova was 1.009 (r = 0.978). Using error grid analysis, the number and percentage of values for Nova were 976 (97.2%) in the A zone and 28 (2.8%) in the B zone. Of 399 data pairs for the Nova device versus YSI, the Nova data points ranged from 46 to 255, whereas YSI ranged from 47 to 231. The coefficient for the slope of YSI versus Nova was 1.023 (r = 0.989). All Nova readings fell in the A zone. Time required for final reading, in duplicate, was 15 seconds for Nova and 120-180 seconds for Beckman and YSI. CONCLUSIONS: The simplicity of Nova and its reliability, accuracy, and speed make it an acceptable replacement device for Beckman and YSI in the conduct of clamps, especially when perturbations require rapid glucose determination.
Authors: Brad S Karon; Laurie Griesmann; Renee Scott; Sandra C Bryant; Jeffrey A Dubois; Terry L Shirey; Steven Presti; Paula J Santrach Journal: Diabetes Technol Ther Date: 2008-04 Impact factor: 6.118
Authors: G A Brunner; M Ellmerer; G Sendlhofer; A Wutte; Z Trajanoski; L Schaupp; F Quehenberger; P Wach; G J Krejs; T R Pieber Journal: Diabetes Care Date: 1998-04 Impact factor: 19.112
Authors: Marissa J Kilberg; Clea Harris; Saba Sheikh; Darko Stefanovski; Marina Cuchel; Christina Kubrak; Denis Hadjiliadis; Ronald C Rubenstein; Michael R Rickels; Andrea Kelly Journal: J Clin Endocrinol Metab Date: 2020-10-01 Impact factor: 5.958
Authors: Andrea Kelly; Diva D De Leon; Saba Sheikh; Devaney Camburn; Christina Kubrak; Amy J Peleckis; Darko Stefanovski; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 21.405
Authors: Andreas Pfützner; Christina Schipper; Sanja Ramljak; Frank Flacke; Jochen Sieber; Thomas Forst; Petra B Musholt Journal: J Diabetes Sci Technol Date: 2013-11-01
Authors: Dariush Elahi; Franca S Angeli; Amin Vakilipour; Olga D Carlson; Eva Tomas; Josephine M Egan; Joel F Habener; Richard P Shannon Journal: Peptides Date: 2014-06-14 Impact factor: 3.750
Authors: Kara A Lindquist; Kelsey Chow; Amy West; Laura Pyle; T Scott Isbell; Melanie Cree-Green; Kristen J Nadeau Journal: Diabetes Technol Ther Date: 2014-01-28 Impact factor: 6.118